CervoMed, Inc. (CRVO)
1.39
-0.06
(-4.14%)
USD |
NASDAQ |
Nov 06, 10:15
CervoMed Market Cap : 18.80M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 19.61M |
| November 04, 2026 | 21.10M |
| November 03, 2026 | 20.97M |
| November 02, 2026 | 22.18M |
| October 30, 2026 | 21.64M |
| October 29, 2026 | 23.67M |
| October 28, 2026 | 29.89M |
| October 27, 2026 | 30.03M |
| October 26, 2026 | 30.30M |
| October 23, 2026 | 31.25M |
| October 22, 2026 | 30.30M |
| October 21, 2026 | 31.65M |
| October 20, 2026 | 30.98M |
| October 19, 2026 | 31.25M |
| October 16, 2026 | 30.30M |
| October 15, 2026 | 30.43M |
| October 14, 2026 | 30.98M |
| October 13, 2026 | 30.70M |
| October 12, 2026 | 33.95M |
| October 09, 2026 | 43.55M |
| October 08, 2026 | 44.37M |
| October 07, 2026 | 43.01M |
| October 06, 2026 | 45.18M |
| October 05, 2026 | 44.77M |
| October 02, 2026 | 40.85M |
| Date | Value |
|---|---|
| October 01, 2026 | 39.63M |
| September 30, 2026 | 40.17M |
| September 29, 2026 | 38.96M |
| September 28, 2026 | 36.12M |
| September 25, 2026 | 34.36M |
| September 24, 2026 | 34.09M |
| September 23, 2026 | 33.95M |
| September 22, 2026 | 34.22M |
| September 21, 2026 | 32.60M |
| September 18, 2026 | 32.87M |
| September 17, 2026 | 34.49M |
| September 16, 2026 | 33.00M |
| September 15, 2026 | 33.14M |
| September 14, 2026 | 34.22M |
| September 11, 2026 | 34.76M |
| September 10, 2026 | 33.54M |
| September 09, 2026 | 33.95M |
| September 08, 2026 | 34.22M |
| September 04, 2026 | 34.63M |
| September 03, 2026 | 34.36M |
| September 02, 2026 | 35.71M |
| September 01, 2026 | 34.76M |
| August 31, 2026 | 35.57M |
| August 28, 2026 | 35.17M |
| August 27, 2026 | 35.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.604B |
| Alnylam Pharmaceuticals, Inc. | 21.25B |
| Anika Therapeutics, Inc. | 224.83M |
| Savara, Inc. | 951.00M |
| Vericel Corp. | 2.613B |
Market Cap Related Metrics
| PS Ratio | 39.87 |
| PEG Ratio | -0.0187 |
| Price to Book Value | 0.8189 |
| Price | 1.39 |
| Earnings Yield | -231.0% |
| PEGY Ratio | -0.0187 |